Tarsus execs discuss origins, treating Demodex blepharitis

Video
Conferences|AAO

Tarsus Pharmaceuticals's CEO Bobby Azamian, MD, PhD, and Chairman Michael Ackermann, PhD, speak on the development of their company and the latest updates on their lead candidate product to treat Demodex blepharitis.

See more AAO coverage

Recent Videos
Related Content
Jane C. Edmond, MD, starts term as 2024 president of AAO

Jane C. Edmond, MD, starts term as 2024 president of AAO

Article
Comparing micro-bypass implant + phaco vs phaco in POAG

Comparing micro-bypass implant + phaco vs phaco in POAG

Podcast
AAO 2023: Luminopia, first FDA-approved digital therapeutic for amblyopia

AAO 2023: Luminopia, first FDA-approved digital therapeutic for amblyopia

Article
Integrating AI to manage DR in a primary care setting

Integrating AI to manage DR in a primary care setting

Podcast
AAO 2023: GALE data at one year

AAO 2023: GALE data at one year

Article
AAO 2023: CoFi company updates and partnership with CareCredit

AAO 2023: CoFi company updates and partnership with CareCredit

Article
© 2024 MJH Life Sciences

All rights reserved.